News

AstraZeneca’s Calquence (acalabrutinib), a next-generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in Japan for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukaemia (CLL) (including small lymphocytic lymphoma ). The approval by the Japanese...

Care Access Research, a decentralized research organization (DRO) that connects physicians and research experts, entered a collaboration with AstraZeneca to accelerate a clinical trial in the U.S. for AZD7442, AstraZeneca’s long-acting monoclonal antibody (LAAB) combination for the potential prevention...

The cost of library preparation is one of the biggest obstacles to large next-generation sequencing (NGS) studies, slowing down the pace of insights from infectious disease surveillance, cancer research and beyond. At the Festival of Genomics, SPT Labtech announced...

Pfizer and BioNTech SE announced an advance purchase agreement with COVAX for up to 40 million doses of the Pfizer-BioNTech COVID-19 Vaccine. The doses will be delivered throughout 2021. COVAX is a global initiative coordinated by the Global Alliance for...

Ubiquigent Limited (Ubiquigent) and the Mottram Laboratory at the University of York announced a collaboration to investigate the inhibition of deubiquitylase (DUB) enzymes expressed by the protozoan Leishmania mexicana for the treatment of leishmaniasis. The collaboration will be supported...

Pelican BioThermal, the global name in temperature controlled packaging, announces its latest partnership with Asiana Airlines, which will see an extensive expansion of the company’s growing global network. In the ongoing rapid response to support the global fight against COVID-19,...

Enara and Boehringer Ingelheim have teamed up to discover and develop novel cancer immunotherapies against overlooked dark antigen targets. How could dark antigens improve the treatment of solid tumour cancers. UK-based Enara Bio has entered into a collaboration with German-headquartered...